The Latest Headlines at American Banking and Market News
Devon Energy (NYSE:DVN) PT Raised to $57.00
Devon Energy (NYSE:DVN – Free Report) had its price objective increased by Mizuho from $53.00 to $57.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has a buy rating on the energy... More of this article »
DuPont de Nemours (NYSE:DD) PT Raised to $83.00
DuPont de Nemours (NYSE:DD – Free Report) had its price objective upped by Mizuho from $76.00 to $83.00 in a research note released on Thursday morning, Benzinga reports. The firm currently has a buy rating on the basic materials... More of this article »
Netflix (NASDAQ:NFLX) Earns Outperform Rating from Analysts at CICC Research
CICC Research started coverage on shares of Netflix (NASDAQ:NFLX – Free Report) in a report released on Thursday, Benzinga reports. The brokerage issued an outperform rating and a $650.00 price target on the Internet television... More of this article »
Mizuho Raises Entegris (NASDAQ:ENTG) Price Target to $143.00
Entegris (NASDAQ:ENTG – Free Report) had its target price upped by Mizuho from $140.00 to $143.00 in a research note issued to investors on Thursday morning, Benzinga reports. They currently have a neutral rating on the semiconductor... More of this article »
LivaNova (NASDAQ:LIVN) Price Target Raised to $80.00
LivaNova (NASDAQ:LIVN – Free Report) had its target price raised by Mizuho from $75.00 to $80.00 in a research report released on Thursday morning, Benzinga reports. The firm currently has a buy rating on the stock. Other equities... More of this article »
AXIS Capital (NYSE:AXS) Raised to Buy at StockNews.com
StockNews.com upgraded shares of AXIS Capital (NYSE:AXS – Free Report) from a hold rating to a buy rating in a research report sent to investors on Friday. Other analysts also recently issued research reports about the stock.... More of this article »
SilverBow Resources (NYSE:SBOW) versus Dorchester Minerals (NASDAQ:DMLP) Financial Analysis
SilverBow Resources (NYSE:SBOW – Get Free Report) and Dorchester Minerals (NASDAQ:DMLP – Get Free Report) are both small-cap oils/energy companies, but which is the superior stock? We will compare the two companies based... More of this article »
Accuray (NASDAQ:ARAY) versus Calmare Therapeutics (OTCMKTS:CTTC) Head-To-Head Analysis
Accuray (NASDAQ:ARAY – Get Free Report) and Calmare Therapeutics (OTCMKTS:CTTC – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their... More of this article »
Stratex Oil & Gas (OTCMKTS:STTX) & Range Resources (NYSE:RRC) Head to Head Analysis
Range Resources (NYSE:RRC – Get Free Report) and Stratex Oil & Gas (OTCMKTS:STTX – Get Free Report) are both oils/energy companies, but which is the better business? We will contrast the two businesses based on the... More of this article »
Morgan Stanley Raises Amgen (NASDAQ:AMGN) Price Target to $310.00
Amgen (NASDAQ:AMGN – Free Report) had its price target upped by Morgan Stanley from $271.00 to $310.00 in a research note issued to investors on Friday, Benzinga reports. Morgan Stanley currently has an equal weight rating on... More of this article »
Globant (NYSE:GLOB) Price Target Cut to $257.00
Globant (NYSE:GLOB – Free Report) had its target price decreased by JPMorgan Chase & Co. from $273.00 to $257.00 in a report issued on Thursday morning, Benzinga reports. JPMorgan Chase & Co. currently has an overweight... More of this article »
EPAM Systems (NYSE:EPAM) PT Lowered to $311.00
EPAM Systems (NYSE:EPAM – Free Report) had its price target trimmed by JPMorgan Chase & Co. from $331.00 to $311.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has an overweight... More of this article »
Truist Financial Corp Purchases 1,423 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Truist Financial Corp lifted its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 4.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor... More of this article »